Apr 25, 2020Science and Technology
Covid - 19: Development Status up date (Apr 20, 2020 to Apr 24, 2020)

Novartis AG: Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease.
Karyopharm Therapeutics Inc.: Announced dosing of first Patient in Randomized Study Evaluating Low Dose Selinexor in Patients with Severe COVID-19


Click on below link to read full article...



Be the first to comment.